UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating
Enovis Corporation (NYSE:ENOV) is one of the best medical device stocks to buy according to analysts. On August 8, UBS lowered the firm’s price target on Enovis Corporation (NYSE:ENOV) to $57 from $...